About Anu
Anu Mavilakandy is a distinguished Patent and Trade Marks Attorney based in Melbourne, Australia, registered in both Australia and New Zealand. She brings a wealth of knowledge, particularly in the biotech and pharmaceutical fields, drawing on her academic background with a Master’s in Pharmacology from the University of Glasgow and a Master of Intellectual Property Law from the University of Melbourne.
Anu's career began in the industry as an Assay Biologist with GlaxoSmithKline in the UK, where her work focused on early-stage drug discovery. This experience spurred her transition to patent law, allowing her to apply her scientific expertise in legal contexts across different international markets, including the UK, Hong Kong, and Australia. Her clientele is diverse, ranging from universities and research institutes to large pharmaceutical companies.
Anu has considerable proficiency in drafting, filing, and prosecuting biotech and medicinal chemistry patents. Her skills extend to preparing Freedom-to-Operate (FTO) and validity opinions, managing extensive patent portfolios, and developing commercialisation strategies. Serving as Special Counsel on a consultancy basis, she enhances patent strategies under LexGeneris' guidance.
Her technical expertise encompasses pharmaceuticals, polymers, biotechnology, and several other scientific domains, showcasing her broad understanding of innovative technologies. This expertise is complemented by her current role as IP Commercialisation Manager at Swinburne University of Technology, where she manages the university's IP portfolio and supports technology commercialisation. Prior roles include contract and IP management positions at the Bionics Institute and experience in international patent prosecution during her tenure in Hong Kong.
Anu's journey through various educational and professional milestones, including her positions at Murgitroyd and as a trainee at Watermark and Marks & Clerk, has equipped her with comprehensive insights into the intricacies of patent law, underscoring her commitment to addressing complex legal and technological challenges efficiently.
